LIVE BLOG
Economic Times | 08 Sep, 2020 | 08.32AM IST
Global Covid-19 cases top 27.2 mn: Johns Hopkins
The overall number of global coronavirus cases has topped 27.2 million, while the deaths have increased to over 891,000, according to the Johns Hopkins University.
!1 New UpdateClick here for latest updates
Global Covid-19 cases top 27.2mn: Johns Hopkins
- The overall number of global coronavirus cases has topped 27.2 million, while the deaths have increased to over 891,000, according to the Johns Hopkins University.
- As of Tuesday morning, the total number of cases stood at 27,002,224 and the fatalities rose to 882,053, the University's Center for Systems Science and Engineering (CSSE) revealed in its latest update.
- The US accounted for the world's highest number of cases and deaths at 6,300,431 and 189,206 respectively, according to the CSSE.
- India is currently in the second place in terms of cases at 4,204,613, while the country's death toll stood at 71,642.
PGI Rohtak to start phase-2 trial of Bharat Biotech's Covid-19 vaccine
- Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine.
- Speaking to ANI, Dr OP Kalra, vice-chancellor, PGI Rohtak said, "We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine. We've 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed."
- "We hope to get vaccine dosages by tomorrow morning," added Kalra.
- Recently, Niti Aayog member Dr Vinod K Paul said that Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila's candidate based on viral DNA are two Indian COVID-19 vaccines in second phase trial.
Second Greece footballer tests positive for Coronavirus
US President Donald Trump has slammed the "rhetoric" against the coronavirus vaccine by Democratic presidential candidate Joe Biden and running mate Senator Kamala Harris, who he said would "never" be the president.
Mexico records 3,486 new coronavirus cases, 223 more deaths
Egypt's COVID-19 case count surpasses 100,000
- The number of recorded cases of the novel coronavirus disease (COVID-19) in Egypt has topped 100,000, the country's Health Ministry said in a statement.
- "The total number of coronavirus cases in Egypt is 100,041 people," ministry spokesman Khaled Mugahed said in a statement obtained by Sputnik.
- Mugahed said that overall, 5,541 patients had died from COVID-19 and more than 79,000 people had recovered.
Around 80 personnel including staff test COVID-19 positive at SVP National Police Academy in Hyderabad
Russian COVID-19 Vaccine released into public
- The first batch of the Sputnik V vaccine against COVID-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliveries are planned in the nearest future, the Russian Health Ministry informs.
- "The first batch of the 'Gam-COVID-Vac' [Sputnik V] vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor [medical device regulator] and has been released into civil circulation," the ministry said in a statement.
- The Russian health ministry registered the first vaccine against COVID-19, named Sputnik V, on August 11.
- Moscow Mayor Sergey Sobyanin expressed hope on Sunday that the majority of the Russian capital's residents would be vaccinated against the coronavirus within several months.
- According to the health ministry, the delivery of the first batches of the Russian vaccine to the country's regions is planned in the nearest future.
Striking trainee doctors return to work as S.Korea battles second virus wave
A request to bring back workers
We've requested Odisha CM Naveen Patnaik to further urge the Central govt to run special trains from Odisha to brin… https://t.co/YQMeBFiu7z
— ANI (@ANI) 1599520004000We got permission from Bharat Biotech to start phase-2 human clinical trial of their vaccine. We've 300 volunteers, aged b/w 12 yrs & 65 yrs, out of which screening of 15 has been completed. We hope to get vaccine dosages by tomorrow morning
- Dr OP Kalra, VC, PGI Rohtak
